Search Results

Follow-On Biologics: The Law and Intellectual Property Issues
This report reviews the Biologics Price Competition and Innovation Act of 2009 (BPCIA), within the context of intellectual property and innovation issues. It provides an introduction to the biologics industry, introduces the regulatory and intellectual property provisions of the BPCIA, considers the potential market for biosimilars and possible industry responses that may arise in the wake of this legislation, and closes with concluding observations.
Gene Patents: A Brief Overview of Intellectual Property Issues
This report provides a brief overview of intellectual property issues on Gene patents. The myriad holding attempts to provide investors and firms with incentives to conduct R&D while recognizing that pattern might obtain too much control in future research
Back to Top of Screen